News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Exelixis, Inc. (EXEL) Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study     9/2/2014
Novo Nordisk A/S (NVO) Drops Inflammatory Disorder Business; 400 Staffers Impacted     9/2/2014
Novartis AG (NVS)'s New Heart Drug Cuts Cardiovascular Death Risk By 20 Percent; "Most Exciting Ever" Med Points To Huge Sales     9/2/2014
Early Phase 3 Data Suggest Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug May Halve Heart Risk     9/2/2014
Belgium Biotech ThromboGenics NV (TBGNF) Cuts Around A Fifth Of Employees     9/2/2014
Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events     9/2/2014
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™     9/2/2014
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab     9/2/2014
Bayer HealthCare (BAY) Starts Its Own Accelerator     9/2/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent     9/2/2014
Baxter International, Inc. (BAX)'s Hunt For Space In Cambridge Triggers A Counter Effort In Illinois     9/2/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Cholesterol-Lowering Medication Evolocumab     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Talimogene Laherparepvec     9/2/2014
Clearside Biomedical Snags $16 Million Series B Financing     9/2/2014

Featured Stories
"Back To Normal" For AstraZeneca PLC (AZN) CEO, Despite Pfizer Inc. (PFE) Rumors     9/2/2014
Wine Only Protects The Heart When You Exercise, Palacky University Study     9/2/2014
Drinking Tea, Not Coffee, Could Help You Live Longer, European Society of Cardiology Reveals     9/2/2014
How Plants In The Office Make Workers More Productive, University of Exeter Study     9/2/2014
Dieting? Low-Carb Trumps Low-Fat For Weight Loss, Heart Health, Tulane University Study     9/2/2014
Energy Drinks Cause Heart Problems, European Society of Cardiology Reveals     9/2/2014
Coffee And Nap Can Increase Alertness, Loughborough University Study     9/2/2014
Boy Born Without A Brain Dies At Age 12     9/2/2014
Chinese Farmer Whose Head Was Crushed Will Be Fitted With 3D-Printed Skull, Xijing Hospital Reveals     9/2/2014
Short Men Make Better Boyfriends And Husbands, New York University Study     8/29/2014
Less Sleep In Teen Years Tied To More Pounds At 21, Columbia University Study     8/29/2014
Centers for Disease Control and Prevention (CDC): There's More Trans Fat Lurking In U.S. Foods Than You Think     8/29/2014
Married Couples Who Smoke Pot Are Happier? University at Buffalo Study     8/29/2014
Certain Toothbrushes Hold 3,000 Times More Germs, University of Texas Health Science Center Researchers Reveal     8/29/2014
Marijuana Compound Could Stop Or Slow Down Alzheimer’s, University of South Florida Study     8/29/2014

More News
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema     9/2/2014
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures     9/2/2014
GE Healthcare Announces European Union Approval Of VIZAMYL™ (Flutemetamol (18F) Solution For Injection) For PET Imaging Of Beta Amyloid Plaque In Suspected Alzheimer’s Disease     9/2/2014
Salix Pharmaceuticals, Ltd. (SLXP) Submits Response To XIFAXAN® 550mg Complete Response Letter Regarding Repeat Treatment For Irritable Bowel Syndrome With Diarrhea     9/2/2014
Ipsen (IPN.PA) Announces Acceptance Of Filings For Somatuline® In The Treatment Of GEP-NET1s In The U.S. With Priority Review And In Europe     9/2/2014
Prosonix' Marketing Authorisation Application For PSX1001 - A Generic Version Of GlaxoSmithKline (GSK)'s Flixotide® Evohaler® - Under Assessment In EU     9/2/2014
Actavis (ACT) Announces FDA Acceptance For Filing Of NDA For Eluxadoline     9/2/2014
Hatchtech Announces Successful Phase 3 Study Results For Xeglyze™ Lotion     9/2/2014
Macrocure (MCUR) Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Curexcell In Diabetic Foot Ulcers     9/2/2014
Sophiris Bio Inc. (SPHS) Reports Completion Of Enrollment In The "PLUS-1" Phase 3 Trial Of PRX302 For Benign Prostatic Hyperplasia     9/2/2014
Teva Pharmaceutical Industries Limited (TEVA)’s Reslizumab Delivers Clinically And Statistically Significant Reduction In Asthma Exacerbations In Two Pivotal Phase 3 Studies     9/2/2014
Ampio Pharmaceuticals, Inc. (AMPE) Release: Update On The Phase 3 Multicenter, Double-Blind STEP Study Of Ampion™ For Osteoarthritis Of The Knee     9/2/2014
Birken Announces Positive Results Of Phase 3 Trials With Oleogel-S10 For Accelerated Wound Healing In Patients With Partial Thickness Wounds     9/2/2014
Conatus Pharmaceuticals Inc. Initiates Phase 2 Trial In Patients With Liver Cirrhosis And Separate Open Label Phase 2 Trial In Cirrhosis Patients With Portal Hypertension     9/2/2014
Alcobra (ADHD) Announces Enrollment Of First Patient In Phase 2b Clinical Trial Of MDX In Adolescents With ADHD     9/2/2014
Cellular Biomedicine Group (CBMG) Launches Clinical Research Study For Cartilage Defect Stem Cell Therapy     9/2/2014
Nuvilex (NVLX) Submits Application For Orphan Drug Designation To The European Medicines Agency For Its Cell-In-A-Box® Treatment For Pancreatic Cancer     9/2/2014
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For The Treatment Of Myelofibrosis     9/2/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Completes Enrollment In Randomized Phase 2 Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome     9/2/2014
VentiRx Pharmaceuticals, Inc. Announces Fast Track Designation Granted For Motolimod (VTX-2337), A Novel Immunotherapy For Women With Ovarian Cancer     9/2/2014
Xention Limited Commences First Phase 2 Study Of XEN-D0103 In Atrial Fibrillation     9/2/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Initiates Phase 1(B) Safety And Tolerance Study For CPP-115     9/2/2014
Capstone Therapeutics (CAPS) Announces Phase 1a Results For AEM-28 Showing Safety And Biomarker Efficacy Signals     9/2/2014
Boston Strategics Corporation Initiates A Phase 1 Clinical Trial Of The Anti-Cancer Agent "FF-10501" For FUJIFILM In Patients With Advanced Hematologic Malignancies     9/2/2014
F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announces Commencement Of A Phase 1 Single Ascending Dose Study Of A Novel Antifungal Agent, F901318.     9/2/2014
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure     9/2/2014
Zogenix, Inc. (ZGNX) Release: Zohydro® ER Demonstrates Sustained 12-Hour Pain Relief     9/2/2014
Boehringer Ingelheim Corporation Release: European Society of Cardiology Congress 2014 Hot Line Session: Favourable Effect Of Pradaxa® On Kidney Function Over Time Compared To Warfarin     9/2/2014
Imperial College London To Present First Public HBV Data From CN Bio Innovations In Vitro Liver Model     9/2/2014
Galleon Pharmaceuticals, Inc. Announces Publication Of Proof-Of-Concept Clinical Studies For GAL-021, Projected Use For The Emerging Perioperative Sleep Apnea Epidemic     9/2/2014
SAGE Therapeutics Presents New Preclinical Data On SAGE-217 At Eilat Conference On New Anti-Epileptic Drugs     9/2/2014
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For Fhe Treatment Of Myelofibrosis     9/2/2014
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment     9/2/2014
Bayer HealthCare (BAY) Release: New Data Show Once-Daily XARELTO® May Be An Alternative To Vitamin K Antagonists In Treating Atrial Fibrillation Patients Undergoing Elective Cardioversion     9/2/2014
Daiichi Sankyo, Inc. (4568.t) Release: One Year Data From The PREFER In AF Registry Show Significant Changes In Atrial Fibrillation (AF) Management In Europe And Implementation Of Clinical Guidelines     9/2/2014
TransCelerate BioPharma Releases Recommended Approach For Protecting Personal Data In Clinical Study Reports     9/2/2014
Exco Intouch Achieve A New First In Mobile Clinical Technology     9/2/2014
Tufts University Release: War Between Bacteria And Phages Benefits Humans     9/2/2014
BioLegend Acquires The Antibody Products Business Unit From Covance Inc. (CVD)     9/2/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China     9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories     9/2/2014
Chimerix, Inc. (CMRX) And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox     9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements     9/2/2014
EMD Group (EMD Millipore Headquarters) And Massachusetts General Hospital Collaborate To Better Understand Systemic Lupus Erythematosus And Lupus Nephritis     9/2/2014
Intrexon Corporation Announces Exclusive Channel Collaboration With Sanofi (France) (SAN.PA) To Optimize Production For A Specific Family Of Active Pharmaceutical Ingredients     9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products     9/2/2014
Lundbeck Inc. (LUN.CO) Announces Availability Of NORTHERA™ (droxidopa) Capsules In The U.S. For Symptomatic Neurogenic Orthostatic Hypotension     9/2/2014
United States Patent & Trademark Office Issues Three New Standard Essential Patents To Spherix (SPEX)     9/2/2014
Marinus Pharmaceuticals (MRNS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock     9/2/2014
Agile Therapeutics, Inc. To Ring The NASDAQ Stock Market Closing Bell     9/2/2014
Aurinia (ISA.TO) To Begin Trading On The NASDAQ Global Market     9/2/2014
Creative BioMart Session---Summary Of August Promotion     9/2/2014
TAP Biosystems Release; Major Pharma Chooses CompacT SelecT Automated Cell Culture SystemTo Generate Consistent, High Quality Cell Plates For Transport Assays     9/2/2014
Cellectis (ALCLS): Genome Engineering & CART Cells: At The Forefront Of Immuno-Oncology     9/2/2014
Lorus Therapeutics Inc. (LRP) Implements Name Change To Aptose Biosciences     9/2/2014
Nordic Nanovector – Subsequent Offering     9/2/2014
VentiRx Pharmaceuticals, Inc. Provides Corporate And Clinical Update     9/2/2014
Agilent Technologies Inc. (A) Introduces Next-Generation Sequencing Cancer Research Panels     9/2/2014
Stellar Biotechnologies, Inc. Reports On Unusual Trading Activity     9/2/2014
Daxor Corporation (DXR) Announces Filing Of Form N-CSR For June 30, 2014     9/2/2014
Allergan Inc. (AGN) Files Answer In Federal Court Responding To Valeant Pharmaceuticals International (VRX) And Pershing Square’s Counterclaims     9/2/2014
U.S. FDA Grants QIDP Status For Wockhardt (WOCKHARDT.BO) Anti-Infective Drug Discovery Program     9/2/2014
DS Healthcare Group To Open Its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies For Hair Loss     9/2/2014
Source BioScience Launches Intelligent GenomeCUBE Search Engine     9/2/2014
Agilent Technologies Inc. (A) Introduces Higher-Performance Q-TOF GC/MS System, Featuring Optimized Hardware/Software Capabilities     9/2/2014
BIOCRATES Life Sciences GmbH Announces Launch Of First-ever Standardized Metabolomics-based Bile Acids Kit     9/2/2014
ERYtech Pharma Business Update And Financial Results For The First Half Of 2014     9/2/2014
Pfenex Inc. (PFNX) Reports Second Quarter 2014 Results And Provides Business Update     9/2/2014
uniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs     9/2/2014
TiGenix Appoints Chief Medical Officer And Vice President Medical Affairs And New Product Commercialisation     9/2/2014
Tokai Pharmaceuticals Appoints Lee Kalowski As Chief Financial Officer     9/2/2014
Mast Therapeutics (MSTX) Announces Management Change     9/2/2014
Sierk Pötting To Be The New CFO (Chief Financial Officer) Of BioNTech Group     9/2/2014
EMD Group (EMD Serono, Inc. (Rockland)) Appoints Drew Young To Senior Vice President, Neurology And Immunology     9/2/2014
Aldeyra Therapeutics (ALDX) Expands Drug Development Team In Advance Of NS2 Clinical Trials     9/2/2014
Distinguished Scientists Join Advanced Cell Technology’s New Scientific Advisory Board     9/2/2014
Cellceutix (CTIX) Appoints Dr. Barry Schechter To Board Of Directors As Company Focuses On Meeting Requirements For Stock Exchange Uplisting     9/2/2014
Aesica Celebrates 10th Anniversary As Eight Fold Increase In Sales Accompanies Successful Transition Into An International Full Service CDMO     9/2/2014
Contract Research Organization WCCT Global Celebrates Being Named As One Of The Fastest Growing Companies In America     9/2/2014
XYMOGEN Ranked Among The Nation's Fastest Growing Private Companies For A Seventh Time     9/2/2014
Linguamatics Ltd I2E Semantic Enrichment Named As A KMworld 2014 Trend-Setting Product     9/2/2014
MediciNova, Inc. To Present Data On MN-001 (Tipelukast) For The Treatment Of Idiopathic Pulmonary Fibrosis (IPF) During The 18th International Colloquium On Lung And Airway Fibrosis (ICLAF)     9/2/2014
Vectura Group plc (VEC.L) Release: Presentations At ERS     9/2/2014
Dipexium Pharmaceuticals (DPRX) Announces Presentation At Rodman & Renshaw 16th Annual Global Investment Conference     9/2/2014
Imperial College London To Present First Public HBV Data From CN Biosciences (CNBI) In Vitro Liver Model     9/2/2014
NephroGenex (NRX) To Participate In Four Healthcare Conferences In September     9/2/2014
Merck & Co., Inc. (MRK) To Present New Data In Five Tumor Types From Studies Evaluating Pembrolizumab, The Company’s Investigational Anti-PD-1 Antibody, At ESMO 2014     9/2/2014
Abaxis, Inc. (ABAX) To Present At CL King's 12th Annual Best Ideas Conference 2014     9/2/2014
Opexa Therapeutics (OPXA) To Present At September Conferences     9/2/2014
Sinovac Biotech Ltd. (SVA) To Participate In Upcoming Investor Conferences     9/2/2014
Bristol-Myers Squibb Company (BMY) Release: Secondary Analysis Of AMPLIFY-EXT Examining Predictors Of Hospitalization Presented At ESC Congress: Eliquis (Apixaban) Significantly Reduced The Risk Of All-Cause Hospitalization Versus Placebo In Patients With Venous Thromboembolism (VTE)     9/2/2014
Agenus (AGEN) To Participate In Two Upcoming Investor Conferences     9/2/2014
Teleflex Incorporated (TFX) To Present For The First Time At The 32nd Annual World Congress Of Endourology And Shockwave Lithotripsy     9/2/2014
OncoSec Medical Inc. To Present At Five Events In September     9/2/2014
CytRx Corporation (CYTR) To Present At Upcoming Investor Conferences In New York City And Las Vegas     9/2/2014
Delenex Therapeutics Release: New Clinical Data On The Topical Application Of PENTRA®Bodies To Be Presented At The 44th Annual ESDR Meeting     9/2/2014
Portola Pharmaceuticals, Inc. To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Versartis, Inc. (VSAR) To Present At The Morgan Stanley (MST) 2014 Global Healthcare Conference     9/2/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
XenoPort, Inc. (XNPT) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Bristol-Myers Squibb Company (BMY) To Take Part In Morgan Stanley (MST) Global Health Care Conference     9/2/2014
Seattle Genetics, Inc. (SGEN) To Present At Morgan Stanley (MST) Healthcare Conference     9/2/2014
Thermo Fisher Scientific (TMO) To Present At The Morgan Stanley (MST) Global Healthcare Conference On September 9, 2014     9/2/2014
Waters Corporation (WAT) Commentary At The Morgan Stanley (MST) Global Healthcare Conference To Be Audio Webcast Live     9/2/2014
Synageva BioPharma (GEVA) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
AVANIR Pharmaceuticals (AVNR) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Spectrum Pharmaceuticals, Inc. (SPPI) To Present Corporate Update At The Morgan Stanley (MST) Global Healthcare Conference In New York City On September 9th     9/2/2014
Ophthotech Corporation (OPHT) To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Acorda Therapeutics (ACOR) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Fluidigm Corporation To Present At Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At 16th Rodman & Renshaw Annual Global Investment Conference     9/2/2014
Celator Pharmaceuticals, Inc. To Present At Rodman & Renshaw 16th Annual Global Investment Conference     9/2/2014
BioLineRx Ltd. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York     9/2/2014
Biocryst Pharmaceuticals (BCRX) To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting     9/2/2014
Dicerna Pharmaceuticals (DRNA) To Present At The Baird 2014 Health Care Conference     9/2/2014

Career Tips
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA)     8/26/2014
Best Biotech Employers In America     8/26/2014
4 Untrue Things Biotech Employers May Tell Candidates     8/21/2014
Top 31 Common Interview Questions And Answers     8/21/2014
6 Tips To Ace Your Next Phone Interview     8/21/2014
How NOT To Write Your Resume     8/21/2014
Cover Letters For The Overqualified: How To Get Your Foot In The Door     8/21/2014
7 Reasons Why Recruiters And Employers Dread Reading A Resume     8/21/2014
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story     8/8/2014
Allergan Inc. (AGN) Layoffs Mean Resume-Tweaking Time: Tips For Creating An Exceptional Resume     8/7/2014
Top Exec Reveals 5 Habits That May Advance Your Career     8/7/2014
11 Hard To Believe Job Search Blunders     8/7/2014
How To Adopt A Recruiter's Mindset When Writing Your Resume     8/7/2014
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker     8/7/2014
Half Of Biotech Employees Dissatisfied With Their Employer     7/24/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->